Xilio Therapeutics, Inc.

Nasdaq:XLO

Pharmaceutical Preparations·WALTHAM, MA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/13/25	→
10-Q	Q2 2025	6/30/25	8/14/25	→
10-Q	Q1 2025	3/31/25	5/8/25	→
10-K	FY 2024	12/31/24	3/11/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→
10-Q	Q2 2024	6/30/24	8/8/24	→
↓

Earnings Releases (8-K)

19 shown

Filed	Period
1/8/26	Q4 FY2026	→
11/13/25	Q4 FY2025	→
8/14/25	Q3 FY2025	→
5/8/25	Q2 FY2025	→
3/11/25	Q1 FY2025	→
11/7/24	Q4 FY2024	→
↓

News (8-K)

39 shown

Filed	Type	Description
2/24/26	Vote	Submission of Matters to a Vote of Security Holders	→
2/12/26	Agreement	Entry into a Material Definitive Agreement	→
1/5/26	Reg FD	Regulation FD Disclosure	→
11/25/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
11/7/25	Reg FD	Regulation FD Disclosure	→
10/3/25	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
↓

Prospectuses & Registrations

23 shown

Filed	Form	Description
2/12/26	424B5	424B5	→
2/11/26	424B5	424B5	→
11/25/25	S-8	S-8	→
6/3/25	424B5	424B5	→
6/2/25	424B5	424B5	→
5/6/25	S-3/A	S-3/A	→
↓

Filing History(321 filings)

TypeDateAccessionPeriodSize

8-K

Feb 24, 2026

0001193125-26-0652348-K

Feb 23, 2026

184.2 KB

Feb 17, 2026

0001123292-26-000187STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Feb 13, 2026

5.7 KB

SCHEDULE 13G/A

Feb 17, 2026

0001193125-26-054804

—

136.6 KB

SCHEDULE 13G/A

Feb 17, 2026

0001104659-26-015985

—

17.0 KB

SCHEDULE 13G/A

Feb 13, 2026

0001231919-26-000149

—

45.6 KB

8-K

Feb 12, 2026

0001193125-26-0489428-K

Feb 11, 2026

513.5 KB

424B5

Feb 12, 2026

0001193125-26-048934424B5

—

766.4 KB

SCHEDULE 13G/A

Feb 12, 2026

0001123292-26-000166

—

6.6 KB

424B5

Feb 11, 2026

0001193125-26-046842424B5

—

57.6 KB

DEF 14A

Jan 26, 2026

0001193125-26-021691DEF 14A

Feb 23, 2026

2.7 MB

PRE 14A

Jan 16, 2026

0001193125-26-015343PRE 14A

Jan 16, 2026

2.7 MB

8-K

Jan 8, 2026

0001193125-26-0070638-K

Jan 6, 2026

217.0 KB

Jan 5, 2026

0001193125-26-0025204

Dec 31, 2025

9.8 KB

Jan 5, 2026

0001193125-26-0025184

Dec 31, 2025

11.5 KB

Jan 5, 2026

0001193125-26-0025174

Dec 31, 2025

11.5 KB

Jan 5, 2026

0001193125-26-0025124

Dec 31, 2025

9.8 KB

8-K

Jan 5, 2026

0001193125-26-0015808-K

Jan 5, 2026

178.0 KB

SCHEDULE 13G

Dec 11, 2025

0001104659-25-120365

—

25.5 KB

Dec 1, 2025

0001123292-25-000675STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Nov 26, 2025

8.7 KB

S-8

Nov 25, 2025

0001193125-25-297243S-8

—

829.1 KB

Nov 25, 2025

0001193125-25-2972074

Nov 21, 2025

18.7 KB

Nov 25, 2025

0001193125-25-2972044

Nov 21, 2025

38.9 KB

Nov 25, 2025

0001193125-25-2972054

Nov 21, 2025

27.2 KB

Nov 25, 2025

0001193125-25-2972034

Nov 21, 2025

38.6 KB

8-K

Nov 25, 2025

0001193125-25-2971658-K

Nov 21, 2025

231.8 KB

25 filings shown

Xilio Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(321 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
1/26/26	DEF 14A	DEF 14A	→
1/16/26	PRE 14A	PRE 14A	→
10/20/25	DEF 14A	DEF 14A	→
10/10/25	PRE 14A	PRE 14A	→
6/3/25	DEFA14A	DEFA14A	→
4/28/25	DEFA14A	DEFA14A	→
↓

Filed	Form	Description
2/17/26	4	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
1/5/26	4	4	→
1/5/26	4	4	→
1/5/26	4	4	→
1/5/26	4	4	→
12/1/25	4	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
↓